Who has invested in Alpha9 Theranostics?

Longitude Capital are named among the investors backing Alpha9 Theranostics.

Alpha9 Theranostics Funding: $86M Raised, Series B (2022)

Alpha9 Theranostics funding overview

Alpha9 Theranostics is based in Vancouver, British Columbia, Canada. Alpha9 Theranostics has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2022. The round record for Alpha9 Theranostics runs through 2022; nothing later has been disclosed. Investors on record include Longitude Capital.

Alpha9 Theranostics at a glance

Total raised: $86M
Latest round: Series B
Latest round date: December 2022
Headquarters: Vancouver, British Columbia, Canada
Notable investors: Longitude Capital

Frequently asked about Alpha9 Theranostics funding

How much has Alpha9 Theranostics raised?: Alpha9 Theranostics has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Alpha9 Theranostics?: Longitude Capital are named among the investors backing Alpha9 Theranostics.
What was the latest Alpha9 Theranostics funding round?: The most recent disclosed round is a Series B, announced in December 2022.
Where is Alpha9 Theranostics based?: Alpha9 Theranostics is based in Vancouver, British Columbia, Canada.
When did Alpha9 Theranostics last raise?: The last disclosed Alpha9 Theranostics round closed in December 2022 at Series B.

Every Alpha9 Theranostics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Vancouver at a similar stage.

Alpha9 Theranostics Funding: $86M Raised, Series B (2022)

Alpha9 Theranostics funding overview

Alpha9 Theranostics at a glance

Frequently asked about Alpha9 Theranostics funding

Companies related to Alpha9 Theranostics (36)

Browse related funding lists (4)